joker, you are right on the mark with your last 3 postings. Don't pay any mind to board cynics such as hackney, the only poster on the board who ever lost a bet on this board --- making the same claim he's now making again, or flea, though one of my favorite posters, has been throwing substance-less spit balls of late.
You're right that the tough patch NLS is now in with revenue and EPS has everything to do with discretionary spending being dampened. NLS is well positioned once this economy revs up, with treadclimber a new breakthrough product, bowflex still solid (albeit with growing comp), the sleep system making headway in a huge market, and now having a hand around its acquisitions (Schwinn & Stairmaster).
Time is an NLS ally. That's why the shorts get desperate when a downtrend doesn't result in a new low.
<<Lying 101: Simply ignore problems like patent expiration in 2004 on your core product, and time is always an ally!>>
Aluisious, nothing personal but you're getting to sound like flea.
As to your spitball, I say:
Inexperience 101: The patent expiration is the oldest news around on this company. Don't you think it's priced in when the company's gone from 45 to a 11 to 16 range? NLS has re-made itself to be something much more than a direct marketing bowflex only company. It's gone retail / commercial / international with additions of Schwinn & Stairmaster. It's begun utilizing the retail segment to sell bowflex with the first numbers reported last qtr. The nautilus sleep system has plenty of comp but it's a vast market and so far it's been a quiet solid growing product line for NLS. And most important of all, treadclimber is set to sail in the two big NLS quarters in the fall & winter.
The patent expiration. My god that's old! Wake up Aluisious.